nothing new in the video... but, just some general quotes:
"we think around $2bn is a fair number, around $14/share AUD it will trade at prior to phase 3"
"all things going right, this could be a major stock in the future, we think the valuation of the business could easily be worth $100/share in the future"
other targets in the pipeline... "MPS, asthma, hayfever, heart disease, kidney disease, RA"
research reports and media, page-300
-
- There are more pages in this discussion • 4,149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $71.73M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 20.0¢ | $152.8K | 744.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 78174 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 84426 | 5 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |